„”
Jonas studies Biotechnology at the Berliner Hochschule für Technik and began his bachelor thesis at the AG Lipstein in 2022. He now continues his work on the mechanisms by which human variations in the essential synaptic protein UNC13A lead to neurodevelopmental disease.
The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10,
13125 Berlin, Germany
